Nuclera

Nuclera provides the eProtein Discovery system, an automated benchtop platform that uses cell-free protein synthesis and digital microfluidics for multiplex protein screening. The technology enables researchers to identify optimal constructs, solubility tags, and expression conditions for soluble, membrane, and antibody proteins within 48 hours. The company serves drug discovery, AI-driven protein design, and structural biology sectors by offering both hardware and protein expression services.